Inspiratory Muscle Training in Pulmonary Hypertension
Primary Purpose
Pulmonary Hypertension
Status
Completed
Phase
Not Applicable
Locations
Turkey
Study Type
Interventional
Intervention
inspiratory muscle training
Sponsored by
About this trial
This is an interventional treatment trial for Pulmonary Hypertension focused on measuring pulmonary hypertension, inspiratory muscle training, functional capacity, physical activity
Eligibility Criteria
Inclusion Criteria:
- Diagnosis of Pulmonary Hypertension,
- NYHA functional class I-IV
- MIP pressure <80 cm h2O
Exclusion Criteria:
- COPD
- Conditions which can limit the assessments
- Insufficient cooperation
Sites / Locations
- Istanbul University
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Inspiratory muscle training group
control group
Arm Description
Patients will continue 8 weeks, 5 days, 2 times 15 minutes training program with %30 MIP at home.
Patients will continue 8 weeks, 5 days, 2 times 15 minutes training program with 9 cmH2O pressure at home.
Outcomes
Primary Outcome Measures
mouth pressures
MIP and MEP
Secondary Outcome Measures
International Physical Activity Questionnaire-Short Form
Physical activity
Minnesota Living with Heart Failure Questionnaire
quality of life
Activity monitoring (Sense wear® Armband)
Metabolic holter
6 minute walking test
functional capacity
Full Information
NCT ID
NCT03385733
First Posted
December 21, 2017
Last Updated
February 28, 2018
Sponsor
Istanbul University
Collaborators
Biruni University
1. Study Identification
Unique Protocol Identification Number
NCT03385733
Brief Title
Inspiratory Muscle Training in Pulmonary Hypertension
Official Title
The Effects of Inspiratory Muscle Training on Exercise Capacity, Physical Activity and Quality of Life in Pulmonary Hypertension
Study Type
Interventional
2. Study Status
Record Verification Date
February 2018
Overall Recruitment Status
Completed
Study Start Date
October 10, 2017 (Actual)
Primary Completion Date
February 15, 2018 (Actual)
Study Completion Date
February 15, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Istanbul University
Collaborators
Biruni University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of this study is to investigate the effective of inspiratory muscle training on respiratory function, exercise capacity, physical activity and quality of life.
Detailed Description
Pulmonary hypertension (PH) is a condition which is seen with hemodynamic differences, pulmonary vascular resistance and right heart failure. Patients with pulmonary hypertension have, dyspnea, physical inactivity, reduced condition and respiratory muscle dysfunction. Aerobic exercise programs in patients with pulmonary hypertension are reported to result in improved exercise capacity and endurance of the patients, improvement in WHO functional class and quality of life, increased peak workload and increased peripheral muscle function. In recent years, few studies have investigated the efficacy of inspiratory muscle training in patients with PH.The aim of this study is to investigate the effective of inspiratory muscle training on respiratory function, exercise capacity, physical activity and quality of life.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pulmonary Hypertension
Keywords
pulmonary hypertension, inspiratory muscle training, functional capacity, physical activity
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Patients will randomize into two groups as Group A: inspiratory muscle training, and Group B (control group)
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
30 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Inspiratory muscle training group
Arm Type
Experimental
Arm Description
Patients will continue 8 weeks, 5 days, 2 times 15 minutes training program with %30 MIP at home.
Arm Title
control group
Arm Type
No Intervention
Arm Description
Patients will continue 8 weeks, 5 days, 2 times 15 minutes training program with 9 cmH2O pressure at home.
Intervention Type
Other
Intervention Name(s)
inspiratory muscle training
Intervention Description
The treatment group received IMT. Patients were trained using an inspiratory threshold-loading device
Primary Outcome Measure Information:
Title
mouth pressures
Description
MIP and MEP
Time Frame
10 minutes
Secondary Outcome Measure Information:
Title
International Physical Activity Questionnaire-Short Form
Description
Physical activity
Time Frame
10 minutes
Title
Minnesota Living with Heart Failure Questionnaire
Description
quality of life
Time Frame
15 minutes
Title
Activity monitoring (Sense wear® Armband)
Description
Metabolic holter
Time Frame
3 days
Title
6 minute walking test
Description
functional capacity
Time Frame
15 minutes
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Diagnosis of Pulmonary Hypertension,
NYHA functional class I-IV
MIP pressure <80 cm h2O
Exclusion Criteria:
COPD
Conditions which can limit the assessments
Insufficient cooperation
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Goksen Kuran Aslan
Organizational Affiliation
Istanbul University
Official's Role
Study Director
Facility Information:
Facility Name
Istanbul University
City
Istanbul
ZIP/Postal Code
34010
Country
Turkey
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
Results of the study will share with other researchers
Learn more about this trial
Inspiratory Muscle Training in Pulmonary Hypertension
We'll reach out to this number within 24 hrs